CME Group plans lawsuit against CFTC over perpetual futures approval

CME Group, the world’s largest derivatives exchange, is preparing to sue its own regulator. Outgoing CEO Terrence Duffy announced on June 17 during CNBC’s “Fast Money” that the exchange will file a lawsuit against the Commodity Futures Trading Commission, challenging the agency’s recent decision to approve perpetual futures contracts for US markets.

The lawsuit, set to be filed on June 18, takes aim at a specific product: KalshiEX LLC’s BTCPERP, a Bitcoin-linked perpetual futures contract that the CFTC greenlit on May 29. It was the first perpetual futures product ever approved for listing on a US regulated exchange. CME’s core argument is straightforward. These products aren’t futures at all, and should instead be classified as swaps under the Dodd-Frank Act.

Why classification matters more than you think

Perpetual futures, the instrument at the center of this fight, are a staple of offshore crypto trading but have never had a home on regulated US exchanges until now. They work like standard futures contracts with one crucial twist: they never expire. Traditional futures have set expiration dates. Perpetuals just keep rolling, indefinitely.

Duffy has been vocal about his concerns. Between June 4 and 5, he flagged what he sees as systemic risks baked into high-leverage products that lack expiration dates. His argument is that the absence of a natural settlement point creates vulnerabilities that traditional futures markets were specifically designed to avoid. The Dodd-Frank Act, passed in the wake of the 2008 financial crisis, created the swaps classification precisely for instruments that don’t fit neatly into the traditional futures framework.

If CME prevails, platforms offering perpetual futures would need to comply with the stricter regulatory requirements that govern swaps. That means higher compliance costs, more capital reserves, and potentially fewer exchanges willing or able to offer these products in the US.

The CFTC fires back

The CFTC isn’t taking this lying down. The agency has dismissed the anticipated claims as “frivolous” and is preparing to contest the lawsuit in court.

CME has every financial incentive to keep perpetual futures off US exchanges, or at least to ensure they face regulatory burdens heavy enough to limit their competitiveness. The exchange’s stock dropped approximately 4.3% on one trading day following the CFTC’s approval, alongside declines at Cboe and ICE. Investors clearly saw the competitive threat.

What this means for crypto traders and investors

If CME wins, perpetual futures would face swap-level regulation. That would likely mean fewer retail-accessible products, higher barriers to entry for exchanges, and a slower rollout of the high-leverage instruments that dominate offshore crypto trading on platforms like Binance and Bybit.

For traders, the practical implications depend on timeline. Lawsuits move slowly, and this one involves complex questions of statutory interpretation under Dodd-Frank. In the near term, KalshiEX’s BTCPERP presumably continues to operate under its existing approval. But the legal uncertainty could dampen institutional appetite for these products until a court weighs in.

The volatility implications extend beyond individual products. The decline in CME, Cboe, and ICE shares after the original CFTC approval was a preview of how sensitive these markets are to shifts in the regulatory landscape for digital asset derivatives.

Disclosure: This article was edited by Editorial Team. For more information on how we create and review content, see our Editorial Policy.